Results 211 to 220 of about 91,213 (314)

Microfluidic platform for understanding Parkinson's disease and α-synuclein conformation. [PDF]

Transl Neurodegener
Pavel T, Georgy Z, Eugenia N, Natalia K, Stanislav Y, Sergey I, Alla S.   +6 more
europepmc   +1 more source

Pathological α-Synuclein Perturbs Nuclear Integrity [PDF]

Michael Millett, Allison Comite, Elisabeth Martin Castosa, Anika Heuberger, P. Wagner, Iluminada Gallardo, Jessica Reinhardt, Nicole Chambers, Dominic Hall, Evan M. Miller, Douglas Nabert, Barbara Balsamo, Stefan Prokop, Mark S. Moehle   +13 more
openalex   +1 more source

A Biomarker‐Based Classification of Corticobasal Syndrome

Movement Disorders, EarlyView.
Abstract Background Corticobasal syndrome (CBS) is a clinically defined syndrome with progressive movement and cortical dysfunction, caused by various underlying pathologies, most commonly tau‐predominant pathologies such as progressive supranuclear palsy and corticobasal degeneration, or Alzheimer's disease (AD).
Carla Palleis, Alexander Maximilian Bernhardt, Endy Weidinger, Urban M. Fietzek, Alexander Jäck, Sabrina Katzdobler, Johannes Gnörich, Theresa Bauer, Nicolai Franzmeier, Robert Perneczky, German Imaging Initiative for Tauopathies (GII4T), Matthias Brendel, Johannes Levin, Günter U. Höglinger   +13 more
wiley   +1 more source

Contribution of α-synuclein cytopathologies to distinct seeding of misfolded α-synuclein. [PDF]

Brain Pathol
Kim A, Martinez-Valbuena I, Danics K, Forrest SL, Kovacs GG.   +4 more
europepmc   +1 more source

Effects of α/β/γ-Synuclein overexpression on the mitochondria and viability of neurons, examined using genetically encoded fluorescent sensors [PDF]

, 2014
Johan Toloe
openalex   +1 more source

Intracellular A53T Mutant α-Synuclein Impairs Adult Hippocampal Newborn Neuron Integration [PDF]

, 2020
Martin Regensburger, Judith Stemick, Eliezer Masliah, Zacharias Kohl, Beate Winner   +4 more
openalex   +1 more source

Reply: “PGRN Manifesting as Parkinson's Disease: Counseling and Treatment Implications”

Movement Disorders Clinical Practice, EarlyView.
Angelo Antonini, Giulia Bonato, Miryam Carecchio   +2 more
wiley   +1 more source

LRRK2 as a Potential Disease‐Modifying Target in Sporadic Parkinson's Disease

Movement Disorders, EarlyView.
Abstract A growing understanding of the role that leucine‐rich repeat kinase 2 (LRRK2) plays in Parkinson's disease (PD) supports continued focus on this enzyme as a therapeutic target for PD. Accumulating evidence suggests that there are phenotypic, neuropathologic, and biological similarities between sporadic PD (sPD) and familial forms in which ...
Anthony E. Lang, Robert A. Hauser, Lorraine V. Kalia, Bonnie Hersh, Zdenek Berger, Roy Llorens Arenas, Coro Paisan‐Ruiz, Kyle Fraser, Danna Jennings, Jillian H. Kluss, Sarah Huntwork‐Rodriguez, Anastasia G. Henry, J. Timothy Greenamyre   +12 more
wiley   +1 more source

Multiomic Analysis Reveals Molecular Pathways Associated with Intestinal Aggregation of α-Synuclein. [PDF]

ACS Chem Biol
Balsamo JM, Yan Y, Thai D, Cologna SM, Bess EN.   +4 more
europepmc   +1 more source

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease [PDF]

, 2018
Jéssika Cristina Bridi, Frank Hirth
openalex   +1 more source